Resources

Diabetes patients tend to overestimate complications risk, treatment benefits.

In your practice, are you seeing more or less patients with prediabetes and diabetes? Follow the link to respond.

A 51-year-old patient returns to your office for a follow-up visit. She is currently taking metformin and glipizide after being diagnosed with type 2 diabetes eight years ago. She shows you her self-care logs that indicate she has been eating a healthy diet and walking daily. She has been maintaining her weight (BMI 26kg/m2). Despite her excellent efforts, her A1C is 7.8%, above her target of A1C<7.0%. When you start to discuss adding a basal insulin dose to her regimen, she bursts into tears. All of the following are common barriers to insulin therapy initiations EXCEPT (follow the link to answer):

In the Look AHEAD study, about 15% had symptoms of mild–moderate depression, about 17% were current users of antidepressant medication, and about 4% both [13]. Other studies in the USA have described higher rates, up to 25%, of more severe depression, with all ethnic groups (white, African-American, Latinos and others) recording similar rates.

Diabetes in Control Publisher Steve Freed meets with Dr. Richard Bergman at the 75th ADA Scientific Sessions in Boston. In this first installment, Dr. Bergman shares his start in diabetes research and explains the high points of his presentation, Comparative Methods for Assessment of Insulin Sensitivity: Oral Vs. Intravenous. Dr. Richard Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.

Diabetes In Control readers submitted their best advice on how to prevent insulin errors at home, at pharmacies, and in the hospital. We're happy to present the winning entry, by Joyce Larson, as well as a selection of other excellent entries.

43-year old patient presents to your clinic for an appointment. She has mild hypertension, which is currently well controlled with a ß-blocker. She was diagnosed with type 2 diabetes 6-years ago, and has been taking metformin and glipizide. She has noticed that her recent self-blood glucose monitoring numbers have been creeping up and with a most recent FPG of 160 mg/dl. At today’s visit, she has an A1C 8.0%. She tells you that until now her job has required she travel several times a month. This week she was promoted to a managerial position that does not require travel. Which of the following approaches would be the best for her?

Just for fun, here's a bonus question to Test Your Knowledge of Thanksgiving: according to food historians, the meal at the first Thanksgiving in 1621 would have been very different from what most U.S. celebrants eat today. In fact, only one of these modern Thanksgiving staples might actually have been on the table back then. Which one is it?

These were the Test Your Knowledge questions that generated the most interest for Diabetes In Control readers in 2015. See how many you remember! [QTL-Question id=29] [QTL-Question id=30] [QTL-Question id=31] [QTL-Question id=32] [QTL-Question id=33]

Much of the literature concerns the important problem of type 2 diabetes and depression and, in comparison with type 1 diabetes, little about the psychological disturbances associated with specific phases of type 2 diabetes.